Laparoscopic Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication - Use Discouraged Due to Increased Risk in Women With Uterine Fibroids
If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis.
Source: FDA MedWatch - Category: American Health Source Type: news
More News: American Health | Cancer & Oncology | Hysterectomy | Laparoscopy | Sarcomas | Uterine Sarcoma | Women